• 1
    Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin 2005; 55: 74108.
  • 2
    Fraumeni JF,Jr, Lloyd JW, Smith EM, Wagoner JK. Cancer mortality among nuns: role of marital status in the etiology of neoplastic disease in women. J Natl Cancer Inst 1969; 42: 45568.
  • 3
    McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 1980; 65: 12017.
  • 4
    Pasi AJ, Robert JM. Chemoprevention of colorectal cancer. New Engl J Med 2000; 342: 19608.
  • 5
    Martineti V, Picariello L, Tognarini I, Sala SC, Gozzini A, Azzari C, Mavilia C, Tanini A, Falchetti A, Fiorelli G, Tonelli F, Brandi ML. ERβ is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocr Relat Cancer 2005; 12: 45569.
  • 6
    Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW. Selective loss of estrogen receptor β in malignant human colon. Cancer Res 2000; 60: 2458.
  • 7
    Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 536540.
  • 8
    Smirnoff P, Liel Y, Gnainsky J, Shany S, Schwartz B. The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor. Oncol Res 1999; 11: 25564.
  • 9
    Odagiri E, Jibiki K, Kato Y, Nakamura S, Oda S-I, Demura R, Demura H. Steroid receptors in dimethylhydrazine-induced colon carcinogenesis. Cancer 1985; 56: 262734.
  • 10
    Fernandez E, La Vecchia C, Balducci A, Chatenoud L, Franceschi S, Negri E. Oral contraceptives and colorectal cancer risk: a meta-analysis. Brit J Cancer 2001; 84: 7227.
  • 11
    Hébert-Croteau N. A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev 1998; 7: 6539.
  • 12
    Grodstein F, Newcomb PA, Stampfer RJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999; 106: 57482.
  • 13
    Martinez ME, Grodstein F, Giovannucci E, Colditz GA, Speizer FE, Hennekens C, Rosner B, Willett WC, Stampfer MJ. A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 15.
  • 14
    Troisi R, Schairer C, Chow WH, Schatzkin A, Brinton LA, Fraumeni JF,Jr. Reproductive factors, oral contraceptive use, and risk of colorectal cancer. Epidemiology 1997; 8: 759.
  • 15
    Beral V, Hermon C, Kay C, Hannaford P, Darby S, Reeves G. Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46,000 women from Royal College of General Practitioners' oral contraception study. Br Med J 1999; 318: 96100.
  • 16
    Hannaford P, Elliott A. Use of exogenous hormones by women and colorectal cancer: evidence from the Royal College of General Practitioner's Oral Contraception Study. Contraception 2005; 71: 958.
  • 17
    Vessey M, Painter R. Oral contraceptive use and cancer: findings in a large cohort study, 1968–2004. Br J Cancer 2006; 95: 3859.
  • 18
    Lin J, Zhang SM, Cook NR, Manson JE, Buring JE, Lee I-M. Oral contraceptives, reproductive factors, and risk of colorectal cancer among women in a prospective cohort study. Am J Epidemiol 2007; 165: 794801.
  • 19
    Terry PD, Jain M, Miller AB, Howe GR, Rohan TE. Dietary carotenoid intake and colorectal cancer risk. Nutr Cancer 2002; 42: 16772.
  • 20
    Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study. I. Breast cancer detection and death rates among women aged 40–49 years. II. Breast cancer detection and death rates among women aged 50–59 years. Can Med Assoc J 1992; 147: 145988.
  • 21
    Jain M, Harrison L, Howe GR, Miller AB. Evaluation of a self-administered dietary questionnaire for use in a cohort study. Am J Clin Nutr 1982; 36: 9315.
  • 22
    Rothman KJ, Greenland S. Modern epidemiology. Philadelphia, PA: Lippincott-Raven, 1998. 319.
  • 23
    Calle EE. Hormone replacement therapy and colorectal cancer: interpreting the evidence. Cancer Causes Control 1997; 8: 1279.
  • 24
    Franceschi S, La Vecchia C. Oral contraceptives and colorectal tumors. Contraception 1998; 58: 33543.
  • 25
    Barrett-Connor E, Grady D, Stefanick ML. The rise and fall of menopausal hormone therapy. Annu Rev Public Health 2005; 26: 11540.
  • 26
    Chute CG. Willett WC, Colditz GA, Stampfer MJ, Rosner B, Speizer FE. A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. Epidemiology 1991; 2: 2017.
  • 27
    Furner SE, Davis FG, Nelson RL, Haenszel W. A case-control study of large bowel cancer and hormone exposure in women. Cancer Res 1989; 49: 493640.
  • 28
    Gerhardsson de Verdier M, London S. Reproductive factors, exogenous female hormones, and colorectal cancer by subsite. Cancer Causes Control 1992; 3: 35560.
  • 29
    Jacobs EJ, White E, Weiss NS. Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control 1994; 5: 35966.
  • 30
    Kampman E, Potter JD, Slattery ML, Caan BJ, Edwards S. Hormone replacement therapy, reproductive history, and colon cancer: a multi-center case-control study. Cancer Causes Control 1997; 8: 14658.
  • 31
    Marcus PM, Newcomb PA, Young T, Storer BE. The association of reproductive and menstrual characteristics and colon and rectal cancer risk in Wisconsin women. Ann Epidemiol 1995; 5: 3039.
  • 32
    Potter JD, Hunter D. Colorectal cancer. In: AdamiH-O, HunterD, TrichopoulosD, eds. Textbook of cancer epidemiology. Oxford: Oxford University Press, 2002; 188211.